Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.
<h4>Background</h4>Reports on metabolic syndrome in nephroblastoma and neuroblastoma survivors are scarce. Aim was to evaluate the occurrence of and the contribution of treatment regimens to the metabolic syndrome.<h4>Patients and methods</h4>In this prospective study 164 sub...
Guardado en:
Autores principales: | Marjolein van Waas, Sebastian J C M M Neggers, Hein Raat, Caroline M van Rij, Rob Pieters, Marry M van den Heuvel-Eibrink |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ffadfb96ee947ea9b104ad69a00df51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A rare pediatric renal tumor: Cystic partially differentiated nephroblastoma
por: Seifeddine Ben Hammouda, et al.
Publicado: (2021) -
Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
por: Marie-Christina Jahreiß, et al.
Publicado: (2021) -
Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein.
por: Wilhelm Bohr, et al.
Publicado: (2010) -
Lithocholic bile acid induces apoptosis in human nephroblastoma cells: a non-selective treatment option
por: Julian Trah, et al.
Publicado: (2020) -
New Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery.
por: Joep P M Derikx, et al.
Publicado: (2008)